$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd

$lgnd Overview Financials Valuation SEC Filings Company Website

2020 Q3 Form 10-Q Financial Statement

#000088616320000122 Filed on November 06, 2020

Income Statement

Concept	2020 Q3	2019 Q4	2019 Q3
Revenue	$41.85M	$27.00M	$24.81M
YoY Change	68.69%	-54.69%	-45.67%
Cost Of Revenue	$6.350M	$1.940M	$3.147M
YoY Change	101.78%	-34.46%	115.55%
Gross Profit	$35.50M	$25.07M	$21.66M
YoY Change	63.89%	-55.74%	-51.0%
Gross Profit Margin	84.83%	92.84%	87.31%
Selling, General & Admin	$15.02M	$10.28M	$9.530M
YoY Change	57.61%	-7.89%	-1.04%
% of Gross Profit	42.31%	41.01%	44.0%
Research & Development	$12.85M	$18.66M	$13.74M
YoY Change	-6.47%	111.09%	150.63%
% of Gross Profit	36.21%	74.43%	63.44%
Depreciation & Amortization	$4.700M	$5.800M	$3.800M
YoY Change	23.68%	75.76%	-29.63%
% of Gross Profit	13.24%	23.14%	17.54%
Operating Expenses	$12.85M	$35.24M	$13.74M
YoY Change	-6.47%	50.09%	150.63%
Operating Profit	$3.747M	-$10.17M	-$5.158M
YoY Change	-172.64%	-130.67%	-122.08%
Interest Expense	$6.269M	$5.490M	$8.993M
YoY Change	-30.29%	-106.15%	-19.71%
% of Operating Profit	167.31%
Other Income/Expense, Net	-$15.36M	-$3.480M	-$14.71M
YoY Change	4.39%	427.27%	-126.34%
Pretax Income	-$11.61M	-$8.180M	-$19.87M
YoY Change	-41.56%	-85.6%	-125.08%
Income Tax	-$4.911M	-$810.0K	-$4.620M
% Of Pretax Income
Net Earnings	-$6.701M	-$7.365M	-$15.25M
YoY Change	-56.06%	-82.66%	-122.64%
Net Earnings / Revenue	-16.01%	-27.27%	-61.48%
Basic Earnings Per Share	-$0.42	-$0.43	-$0.81
Diluted Earnings Per Share	-$0.42	-$0.43	-$0.81
COMMON SHARES
Basic Shares Outstanding	16.08M shares	17.24M shares	18.77M shares
Diluted Shares Outstanding	16.08M shares	17.24M shares	18.77M shares

Balance Sheet

Concept	2020 Q3	2019 Q4	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$795.1M	$1.070B	$1.150B
YoY Change	-30.83%	39.93%	3.38%
Cash & Equivalents	$456.9M	$71.54M	$225.3M
Short-Term Investments	$338.2M	$998.3M	$924.2M
Other Short-Term Assets	$3.191M	$4.734M	$5.039M
YoY Change	-36.67%	-57.04%	-80.11%
Inventory	$13.43M	$7.296M	$6.565M
Prepaid Expenses
Receivables	$32.91M	$30.39M	$22.00M
Other Receivables	$0.00	$11.30M	$0.00
Total Short-Term Assets	$857.7M	$1.124B	$1.183B
YoY Change	-27.5%	29.07%	-32.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.157M	$7.185M	$6.411M
YoY Change	11.64%	33.75%	45.47%
Goodwill	$102.1M	$95.23M	$93.51M
YoY Change	9.22%	9.91%	8.79%
Intangibles	$224.6M	$210.4M	$216.3M
YoY Change	3.84%	-4.25%	0.0%
Long-Term Investments	$813.0K	$750.0K	$49.86M
YoY Change	-98.37%	-98.65%
Other Assets	$13.70M	$2.273M	$2.488M
YoY Change	450.8%	382.59%	398.6%
Total Long-Term Assets	$389.7M	$371.3M	$364.4M
YoY Change	6.95%	-4.87%	1.07%
TOTAL ASSETS
Total Short-Term Assets	$857.7M	$1.124B	$1.183B
Total Long-Term Assets	$389.7M	$371.3M	$364.4M
Total Assets	$1.247B	$1.495B	$1.547B
YoY Change	-19.39%	18.57%	-26.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.17M	$2.420M	$2.040M
YoY Change	398.48%	-42.15%	23.86%
Accrued Expenses	$14.50M	$8.581M	$13.06M
YoY Change	11.01%	-55.31%	40.93%
Deferred Revenue	$5.404M	$2.139M	$2.230M
YoY Change	142.33%	-34.91%	-8.98%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$42.30M	$17.00M	$35.70M
YoY Change	18.5%	-79.33%	-95.5%
LONG-TERM LIABILITIES
Long-Term Debt	$455.0M	$639.0M	$631.5M
YoY Change	-27.95%	4.77%	4.76%
Other Long-Term Liabilities	$25.32M	$22.48M	$7.979M
YoY Change	217.33%	2263.83%	709.23%
Total Long-Term Liabilities	$25.32M	$22.48M	$7.979M
YoY Change	217.33%	2263.83%	709.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$42.30M	$17.00M	$35.70M
Total Long-Term Liabilities	$25.32M	$22.48M	$7.979M
Total Liabilities	$549.6M	$727.7M	$696.9M
YoY Change	-21.13%	3.97%	-50.44%
SHAREHOLDERS EQUITY
Retained Earnings	$386.2M	$400.1M	$407.5M
YoY Change	-5.22%	-274.57%	-321.55%
Common Stock	$16.00K	$17.00K	$17.00K
YoY Change	-5.88%	-19.05%	-19.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$697.8M	$767.2M	$850.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.247B	$1.495B	$1.547B
YoY Change	-19.39%	18.57%	-26.51%

Cashflow Statement

Concept	2020 Q3	2019 Q4	2019 Q3
OPERATING ACTIVITIES
Net Income	-$6.701M	-$7.365M	-$15.25M
YoY Change	-56.06%	-82.66%	-122.64%
Depreciation, Depletion And Amortization	$4.700M	$5.800M	$3.800M
YoY Change	23.68%	75.76%	-29.63%
Cash From Operating Activities	$12.70M	-$7.300M	-$6.200M
YoY Change	-304.84%	-122.39%	-122.88%
INVESTING ACTIVITIES
Capital Expenditures		-$2.600M
YoY Change		-76.15%
Acquisitions
YoY Change
Other Investing Activities	$332.1M	-$60.60M	$169.5M
YoY Change	95.93%	-121.17%	-315.37%
Cash From Investing Activities	$332.1M	-$63.20M	$169.5M
YoY Change	95.93%	-122.96%	-316.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.700M	-83.70M	-211.3M
YoY Change	-98.25%	-75.89%	-458.74%
NET CHANGE
Cash From Operating Activities	12.70M	-7.300M	-6.200M
Cash From Investing Activities	332.1M	-63.20M	169.5M
Cash From Financing Activities	-3.700M	-83.70M	-211.3M
Net Change In Cash	341.1M	-154.2M	-48.00M
YoY Change	-810.62%	293.37%	-723.38%
FREE CASH FLOW
Cash From Operating Activities	$12.70M	-$7.300M	-$6.200M
Capital Expenditures		-$2.600M
Free Cash Flow		-$4.700M
YoY Change		-110.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q3	us-gaap	Short Term Investments ShortTermInvestments	338154000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000886163
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
CY2020Q3	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P7Y
CY2020Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P7Y
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33093
	dei	Entity Registrant Name EntityRegistrantName	LIGAND PHARMACEUTICALS INCORPORATED
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0160744
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3911 Sorrento Valley Boulevard, Suite 110
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
	dei	City Area Code CityAreaCode	858
	dei	Local Phone Number LocalPhoneNumber	550-7500
	dei	Security12b Title Security12bTitle	Common Stock , par value $0.001 per share
	dei	Trading Symbol TradingSymbol	LGND
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16091319	shares
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	456916000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71543000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	998324000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32907000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30387000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	13430000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	7296000	USD
CY2020Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	11361000	USD
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	3191000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4734000	USD
CY2020Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	13143000	USD
CY2019Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	857741000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	1123645000	USD
CY2020Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	27026000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	25608000	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	224582000	USD
CY2020Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	674000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	210448000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	102136000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	95229000	USD
CY2020Q3	lgnd	Commercial License Rights CommercialLicenseRights	10834000	USD
CY2019Q4	lgnd	Commercial License Rights CommercialLicenseRights	20090000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7157000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7185000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4269000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10353000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13704000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2357000	USD
CY2020Q3	us-gaap	Assets Assets	1247449000	USD
CY2019Q4	us-gaap	Assets Assets	1494915000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	10169000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2420000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14498000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9836000	USD
CY2019Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	USD
CY2020Q3	lgnd	Current Portion Of Liability For Contingent Value Rights CurrentPortionOfLiabilityForContingentValueRights	1194000	USD
CY2019Q4	lgnd	Current Portion Of Liability For Contingent Value Rights CurrentPortionOfLiabilityForContingentValueRights	2607000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5404000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2139000	USD
CY2020Q3	lgnd	Liabilities Related To Assets Held For Sale Not Part Of Disposal Group Current LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent	10361000	USD
CY2019Q4	lgnd	Liabilities Related To Assets Held For Sale Not Part Of Disposal Group Current LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	42300000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17002000	USD
CY2020Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	454973000	USD
CY2019Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	638959000	USD
CY2020Q3	lgnd	Liability For Contingent Value Rights LiabilityForContingentValueRights	9604000	USD
CY2019Q4	lgnd	Liability For Contingent Value Rights LiabilityForContingentValueRights	6335000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	13508000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	32937000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3920000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9970000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	25320000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	22480000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	549625000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	727683000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16091000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16091000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16823000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16823000	shares
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	16000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	17000	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	313057000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	367326000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1441000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-216000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	386192000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	400105000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	697824000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	767232000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1247449000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1494915000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	41848000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	24808000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	116429000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	93279000	USD
CY2020Q3	us-gaap	Cost Direct Material CostDirectMaterial	6353000	USD
CY2019Q3	us-gaap	Cost Direct Material CostDirectMaterial	3147000	USD
	us-gaap	Cost Direct Material CostDirectMaterial	18680000	USD
	us-gaap	Cost Direct Material CostDirectMaterial	9410000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	3875000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	3552000	USD
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	11285000	USD
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	10560000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12853000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13742000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	37476000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	37244000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15020000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9525000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34353000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31607000	USD
CY2020Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	38101000	USD
CY2019Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	29966000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	101794000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	6269000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	8993000	USD
	us-gaap	Interest Expense InterestExpense	21030000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	88821000	USD
CY2020Q3	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	0	USD
CY2019Q3	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	0	USD
	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	0	USD
	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	812797000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3747000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5158000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	14635000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	817255000	USD
CY2020Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-9862000	USD
CY2019Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-13297000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-17143000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-8524000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	991000	USD
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	7396000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	7690000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	22590000	USD
	us-gaap	Interest Expense InterestExpense	26911000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-219000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	181000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1940000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	404000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15359000	USD
CY2019Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14713000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-28543000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-12441000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-11612000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-19871000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-13908000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	804814000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4911000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4620000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5162000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	168147000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-6701000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-15251000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8746000	USD
	us-gaap	Net Income Loss NetIncomeLoss	636667000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.81
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.54
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	32.51
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16082000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18770000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16222000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19586000	shares
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.81
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.54
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	31.29
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16082000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18770000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16222000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20349000	shares
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-6701000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-15251000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8746000	USD
	us-gaap	Net Income Loss NetIncomeLoss	636667000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-54000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-187000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-84000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	546000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	923000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-764000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1141000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1015000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5832000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16202000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9971000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	636198000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	767232000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-1008000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5653000	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	73287000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-2772000	USD
CY2020Q1	lgnd	Adjustments To Additional Paid In Capital Foreign Currency Translation Adjustment AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment	-1879000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-2745000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-24131000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	661896000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1128000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7359000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	2742000	USD
CY2020Q2	lgnd	Adjustments To Additional Paid In Capital Foreign Currency Translation Adjustment AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment	-185000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-23000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	22086000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	695003000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	910000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7740000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-54000	USD
CY2020Q3	lgnd	Adjustments To Additional Paid In Capital Foreign Currency Translation Adjustment AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment	923000	USD
CY2020Q3	us-gaap	Stockholders Equity Other StockholdersEquityOther	-3000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-6701000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	697824000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	560914000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-991000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5347000	USD
CY2019Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	151585000	USD
CY2019Q1	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	230000	USD
CY2019Q1	lgnd	Adjustments To Additional Paid In Capital Foreign Currency Translation Adjustment AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment	291000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-569000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	666337000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5000000.0	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	1079974000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	740000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6571000	USD
CY2019Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	33717000	USD
CY2019Q2	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	503000	USD
CY2019Q2	lgnd	Adjustments To Additional Paid In Capital Foreign Currency Translation Adjustment AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment	-542000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2343000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-14419000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	1041453000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	199000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6297000	USD
CY2019Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	181188000	USD
CY2019Q3	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-187000	USD
CY2019Q3	lgnd	Adjustments To Additional Paid In Capital Foreign Currency Translation Adjustment AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment	-764000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	22000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-15251000	USD
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P3Y
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	850581000	USD
	us-gaap	Profit Loss ProfitLoss	-8746000	USD
	us-gaap	Profit Loss ProfitLoss	636667000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	812797000	USD
	lgnd	Non Cash Change In Estimated Fair Value Of Contingent Value Rights NonCashChangeInEstimatedFairValueOfContingentValueRights	397000	USD
	lgnd	Non Cash Change In Estimated Fair Value Of Contingent Value Rights NonCashChangeInEstimatedFairValueOfContingentValueRights	-762000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12645000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11648000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1507000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	7477000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	17743000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	22562000	USD
	lgnd	Amortization Of Other Economic Rights AmortizationOfOtherEconomicRights	2505000	USD
	lgnd	Amortization Of Other Economic Rights AmortizationOfOtherEconomicRights	10047000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	659000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	lgnd	Increase Decrease In Other Economic Rights IncreaseDecreaseInOtherEconomicRights	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	20752000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	18215000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	19311000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-57766000	USD
	lgnd	Gain Loss On Short Term Investments GainLossOnShortTermInvestments	-17143000	USD
	lgnd	Gain Loss On Short Term Investments GainLossOnShortTermInvestments	-8524000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-1525000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-4253000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5080000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-33892000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4914000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1500000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9894000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3302000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	12026000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	16571000	USD
	lgnd	Increase Decrease In Other Economic Rights IncreaseDecreaseInOtherEconomicRights	12000000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	466000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2678000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	54049000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21997000	USD
	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	0	USD
	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	812797000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	337016000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	1682586000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	389296000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	144182000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	589155000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	1274851000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	26857000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	11840000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	500000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	228000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	6307000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	613850000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	530097000	USD
	us-gaap	Proceeds From Hedge Financing Activities ProceedsFromHedgeFinancingActivities	0	USD
	us-gaap	Proceeds From Hedge Financing Activities ProceedsFromHedgeFinancingActivities	12401000	USD
	us-gaap	Payments For Hedge Financing Activities PaymentsForHedgeFinancingActivities	0	USD
	us-gaap	Payments For Hedge Financing Activities PaymentsForHedgeFinancingActivities	12401000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2459000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2856000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1429000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2906000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	73287000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	371106000	USD
	lgnd	Payments To Contingent Value Right Holders Financing Activity PaymentsToContingentValueRightHoldersFinancingActivity	2325000	USD
	lgnd	Payments To Contingent Value Right Holders Financing Activity PaymentsToContingentValueRightHoldersFinancingActivity	3000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-5224000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5800000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	8300000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-283016000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-401479000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-50000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-88000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	384833000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	106533000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72273000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119780000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	457106000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	226313000	USD
	us-gaap	Interest Paid Net InterestPaidNet	2531000	USD
	us-gaap	Interest Paid Net InterestPaidNet	3015000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2130000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	93817000	USD
CY2020Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	190000	USD
CY2019Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	1011000	USD
CY2019Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1000000.0	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	381000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
	lgnd	Accrued Inventory Purchases AccruedInventoryPurchases	1390000	USD
	lgnd	Accrued Inventory Purchases AccruedInventoryPurchases	0	USD
	lgnd	Accrued Lease Purchases AccruedLeasePurchases	2500000	USD
	lgnd	Accrued Lease Purchases AccruedLeasePurchases	0	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-109000	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	699000	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, effective the second quarter of 2020, we began to include our investment in Viking in “short-term investments” in the condensed consolidated balance sheet, and present “gain (loss) from short-term investments” in the condensed consolidated statements of operations to include both the gain (loss) from investment in Viking and other short-term investments, which was previously included in “other income, net”. As a result, the audited consolidated balance sheet as of December 31, 2019 and the condensed consolidated statements of operations for the three and nine months ended September 30, 2019 have been reclassified to conform to the current period presentation.</span></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div>
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	41848000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	24808000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	116429000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	93279000	USD
CY2020Q3	lgnd	Debt Securities Available For Sale And Equity Securities Fvni Amortized Cost DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost	299291000	USD
CY2020Q3	lgnd	Debt Securities Available For Sale And Equity Securities Fvni Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax	1037000	USD
CY2020Q3	lgnd	Debt Securities Available For Sale And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax	2624000	USD
CY2020Q3	lgnd	Debt Securities Available For Sale And Equity Securities Fvni DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI	297704000	USD
CY2019Q4	lgnd	Debt Securities Available For Sale And Equity Securities Fvni Amortized Cost DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost	941174000	USD
CY2019Q4	lgnd	Debt Securities Available For Sale And Equity Securities Fvni Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax	933000	USD
CY2019Q4	lgnd	Debt Securities Available For Sale And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax	2118000	USD
CY2019Q4	lgnd	Debt Securities Available For Sale And Equity Securities Fvni DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI	939989000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	121452000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	121610000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	21842000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	21947000	USD
CY2020Q3	lgnd	Debt Securities Available For Sale Maturity Allocated And Single Maturity Date Rolling After Five Years Amortized Cost DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost	0	USD
CY2020Q3	lgnd	Debt Securities Available For Sale Maturity Allocated And Single Maturity Date Rolling After Five Years Fair Value DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue	0	USD
CY2020Q3	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	143294000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	143557000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	400	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	8018000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	400	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	8018000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	19000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	137947000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2020Q1	lgnd	Commercial License And Other Economic Rights Allowance For Credit Loss CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss	5500000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	19000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	137947000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	2	position
CY2020Q3	lgnd	Covid19 Accounts Receivable Allowance For Credit Loss Period Increase Decrease COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease	-100000	USD
	lgnd	Covid19 Accounts Receivable Allowance For Credit Loss Period Increase Decrease COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease	200000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	102136000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	95229000	USD
CY2020Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	326718000	USD
CY2019Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	305677000	USD
	lgnd	Commercial License And Other Economic Rights Increase Decrease To Allowance For Credit Loss During Period CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod	500000	USD
CY2020Q3	lgnd	Ramp Up Fee Asset Noncurrent RampUpFeeAssetNoncurrent	9215000	USD
CY2019Q4	lgnd	Ramp Up Fee Asset Noncurrent RampUpFeeAssetNoncurrent	0	USD
CY2020Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2000000	USD
CY2019Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	0	USD
CY2020Q3	us-gaap	Equity Method Investments EquityMethodInvestments	813000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	750000	USD
CY2020Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	138000	USD
CY2019Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	219000	USD
CY2020Q3	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1538000	USD
CY2019Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1388000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13704000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2357000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4840000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1986000	USD
CY2020Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1226000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1135000	USD
CY2020Q3	lgnd	Licensee Accrual Current LicenseeAccrualCurrent	407000	USD
CY2019Q4	lgnd	Licensee Accrual Current LicenseeAccrualCurrent	381000	USD
CY2020Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	805000	USD
CY2019Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	0	USD
CY2020Q3	lgnd	Returns Accrual ReturnsAccrual	2835000	USD
CY2019Q4	lgnd	Returns Accrual ReturnsAccrual	3027000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1029000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1242000	USD
CY2020Q3	us-gaap	Interest Payable Current InterestPayableCurrent	1437000	USD
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	690000	USD
CY2020Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1919000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1375000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14498000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9836000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	7740000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	6297000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	20752000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	18215000	USD
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.003
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.016
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.010
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.024
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.59
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.55
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.43
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M24D
CY2019Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y3M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y9M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y2M12D
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	16082000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	18770000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	16222000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19586000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	0	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	0	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	0	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	35000	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	728000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16082000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18770000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16222000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20349000	shares
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7028000	shares
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11549000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8330000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8694000	shares
CY2020Q3	lgnd	Short Term Investments Fair Value Disclosure ShortTermInvestmentsFairValueDisclosure	297704000	USD
CY2019Q4	lgnd	Short Term Investments Fair Value Disclosure ShortTermInvestmentsFairValueDisclosure	939989000	USD
CY2020Q3	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	33869000	USD
CY2019Q4	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	48425000	USD
CY2020Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	6581000	USD
CY2019Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	9910000	USD
CY2020Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	338154000	USD
CY2019Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	998324000	USD
CY2020Q3	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	71000	USD
CY2019Q4	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	75000	USD
CY2020Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	10869000	USD
CY2019Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	9017000	USD
CY2020Q2	lgnd	Payments To Contingent Value Right Holders And Other Contingency Payments Investing Activities PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities	1800000	USD
CY2010Q1	lgnd	Number Of Contingent Value Rights Series NumberOfContingentValueRightsSeries	4	contingentValueRightSeries
CY2020Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.423
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.371
CY2019Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.232
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.209
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1600000	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	72.60
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	73300000	USD
CY2020Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
CY2020Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
CY2019Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000.0	USD
CY2019Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P3Y
CY2020Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	253500000	USD
CY2019Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	USD
CY2020Q3	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	2581000	USD
CY2020Q3	us-gaap	Disposal Group Including Discontinued Operation Other Current Assets DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets	2871000	USD
CY2020Q3	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Current DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent	2445000	USD
CY2020Q3	lgnd	Disposal Group Including Discontinued Operation Operating Lease Right Of Use Assets Current DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent	5246000	USD
CY2020Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	13143000	USD
CY2020Q3	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent	463000	USD
CY2020Q3	us-gaap	Disposal Group Including Discontinued Operation Accrued Liabilities Current DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent	1697000	USD
CY2020Q3	us-gaap	Disposal Group Including Discontinued Operation Deferred Revenue Current DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent	2464000	USD
CY2020Q3	lgnd	Disposal Group Including Discontinued Operation Operating Lease Liability Current DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent	5084000	USD
CY2020Q3	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	653000	USD
CY2020Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	10361000	USD

Files In Submission

Name	View Source	Status
0000886163-20-000122-index-headers.html	Edgar Link	pending
0000886163-20-000122-index.html	Edgar Link	pending
0000886163-20-000122.txt	Edgar Link	pending
0000886163-20-000122-xbrl.zip	Edgar Link	pending
exhibit102ligandcydexg.htm	Edgar Link	pending
exhibit25ligand-cvragr.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lgnd-20200930.htm	Edgar Link	pending
lgnd-20200930.xsd	Edgar Link	pending
lgnd-20200930_cal.xml	Edgar Link	unprocessable
lgnd-20200930_def.xml	Edgar Link	unprocessable
lgnd-20200930_g1.jpg	Edgar Link	pending
lgnd-20200930_htm.xml	Edgar Link	completed
lgnd-20200930_lab.xml	Edgar Link	unprocessable
lgnd-20200930_pre.xml	Edgar Link	unprocessable
lgnd_93020exhibit311.htm	Edgar Link	pending
lgnd_93020exhibit312.htm	Edgar Link	pending
lgnd_93020exhibit321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd

2020 Q3 Form 10-Q Financial Statement

#000088616320000122 Filed on November 06, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGND LIGAND PHARMACEUTICALS INC Stock $lgnd

2020 Q3 Form 10-Q Financial Statement

#000088616320000122 Filed on November 06, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd